1. Home
  2. IVT vs ANIP Comparison

IVT vs ANIP Comparison

Compare IVT & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InvenTrust Properties Corp.

IVT

InvenTrust Properties Corp.

HOLD

Current Price

$28.62

Market Cap

2.2B

Sector

Real Estate

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$76.22

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IVT
ANIP
Founded
2005
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IVT
ANIP
Price
$28.62
$76.22
Analyst Decision
Buy
Strong Buy
Analyst Count
6
6
Target Price
$32.20
$105.83
AVG Volume (30 Days)
555.4K
462.3K
Earning Date
02-10-2026
02-27-2026
Dividend Yield
3.31%
N/A
EPS Growth
1421.59
N/A
EPS
1.51
1.67
Revenue
$293,020,000.00
$826,880,000.00
Revenue This Year
$9.77
$44.06
Revenue Next Year
$7.05
$9.06
P/E Ratio
$19.00
$45.54
Revenue Growth
9.60
48.87
52 Week Low
$25.21
$52.74
52 Week High
$31.04
$99.50

Technical Indicators

Market Signals
Indicator
IVT
ANIP
Relative Strength Index (RSI) 52.72 34.94
Support Level $28.42 $76.69
Resistance Level $29.50 $80.29
Average True Range (ATR) 0.48 2.79
MACD 0.02 -0.14
Stochastic Oscillator 52.57 7.87

Price Performance

Historical Comparison
IVT
ANIP

About IVT InvenTrust Properties Corp.

InvenTrust Properties Corp is the United States of America based company qualified as a REIT (Real Estate Investment Trust). It is focused on owning, leasing, redeveloping, acquiring and managing a multi-tenant retail platform. The company's wholly-owned and managed retail properties include grocery-anchored community and neighborhood centers and power centers, including those classified as necessity-based. InvenTrust operates through a single segment i.e. multi-tenant retail.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: